Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
about
Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysisSystematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaTMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray dataRole of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysisDown-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition.Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.RON is not a prognostic marker for resectable pancreatic cancer.Effect of pre-operative red blood cell distribution on cancer stage and morbidity rate in patients with pancreatic cancerSerum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinomaMeta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival.CT contrast enhancement correlates with pathological grade and microvessel density of pancreatic cancer tissuesPrognosis Relevance of Serum Cytokines in Pancreatic Cancer.Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations.Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry StudiesA randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trialPancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysisTherapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.The estimation of metaloproteinases and their inhibitors blood levels in patients with pancreatic tumors.Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repositoryRABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.A meta-analysis of gemcitabine biomarkers in patients with pancreaticobiliary cancers.Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer.Protumor and antitumor functions of neutrophil granulocytes.Gene of the month: E-cadherin (CDH1).Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.
P2860
Q27004677-A81AB0A0-C09A-4EC1-83E9-FC94EADF08CCQ28085367-EAAE862B-94E1-454C-9877-F76C25D00A27Q30486190-68338CAC-A559-42C1-AAE1-CF6517B6F982Q33982773-9FA1973F-5DEA-47DA-894F-D23B71E2AE55Q34212175-61E83884-58A9-4F0A-83B2-402AD9B5CBADQ34291356-292F2726-7AED-4825-A40E-F925017B42F3Q34336268-2617A158-1904-4E50-B2BF-0C75B61D4C27Q34385867-7F3107AA-384C-4F0A-A77E-73CBBB3F4D42Q34408923-614DB223-5522-43C1-A0D4-29C8CF529ABBQ34415272-D5A8A462-CFD9-4610-B452-CDE58DA31969Q34483897-35E1CDC8-E421-43E6-886D-FFCF843E42B5Q35080302-7FE00F4F-D8F8-4A9F-8A48-50E1C8F4CD6DQ35320095-2A42680B-CED5-4907-8FDA-4E731FBE4E49Q35656610-E98A5518-BE6A-43BE-8EA8-5A6F0744F11DQ35820525-A682C26D-009B-4BB1-A65D-318CB5C1727FQ35854203-A70E19FA-A875-4643-8FBC-326C47865939Q35963911-9CCB77AA-4965-4077-87BE-8586D26FE920Q36000813-7AE018C2-8686-45F3-A64B-86B4B9B2F346Q36027644-25DBF145-E3D9-4D2D-902D-2CB69DBB7104Q36105571-D35C2C4E-EE0C-472D-8482-E11B1F3DF9EDQ36131174-A6422141-7A45-4DE6-8184-1CBBE562B03BQ36443870-0AD70CB9-45D6-4737-9EBA-2956116AF956Q36571451-BEED267C-8B00-4B26-B7AC-0CEA97CAFE8EQ36849427-4184D8A2-2101-47B9-AEDC-A6BB96884107Q36860719-690627B1-A5F7-4214-A9A5-0E977907CDA1Q36958365-B716ED0F-D56A-4DC9-BDB2-D7B0C62D5236Q36982788-61AA0A22-8B76-4440-99C1-3D607333C9DBQ37226804-44A292E1-546C-4E8D-AEEF-30EF6FFECB25Q37253577-0EB460D0-E54A-42D1-8F5C-249308C34CF6Q37259570-8C8A09D2-CCC2-4BC9-A123-939944DB9FD1Q37268613-E8F6A96C-096F-4BE4-A204-62B17D2D641FQ37314018-74B061F5-DBE3-4FAE-8267-07B80C5758DCQ37569554-1516E32E-CE14-4537-A888-F1D7610C3CF2Q38046098-9D30EC74-2B40-4C1A-BED4-C0D221F00B4EQ38128549-D252990F-A300-47B4-BEBC-02930703CD6AQ38148062-1A965BE9-B9E6-489A-B24C-A2C0C8954FD1Q38157778-5981D14A-8717-4BDE-AE35-D246A55C25E9Q38208583-815EB3DE-EB37-4249-9E66-6C491DB3BDFEQ38254499-AC98C2E7-BF9A-4844-A855-D757E401621BQ38259536-035B4413-DEB2-45FF-8FEC-C8D2B476E5B7
P2860
Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@en
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@nl
type
label
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@en
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@nl
prefLabel
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@en
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@nl
P2093
P921
P1476
Tissue biomarkers for prognosi ...... atic review and meta-analysis.
@en
P2093
C Ross Carter
Colin J McKay
Karin A Oien
Nigel B Jamieson
P304
P356
10.1158/1078-0432.CCR-10-3284
P407
P577
2011-03-28T00:00:00Z